The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
Progression from asymptomatic smoldering multiple myeloma (SMM) to symptomatic Multiple Myeloma occurs at different rates in different patients. Here, the authors report fewer NRAS and FAM46C mutations and adverse translocations in SMM compared to MM, while KRAS mutations are associated with a short...
Main Authors: | Eileen M. Boyle, Shayu Deshpande, Ruslana Tytarenko, Cody Ashby, Yan Wang, Michael A. Bauer, Sarah K. Johnson, Christopher P. Wardell, Sharmilan Thanendrarajan, Maurizio Zangari, Thierry Facon, Charles Dumontet, Bart Barlogie, Arnaldo Arbini, Even H. Rustad, Francesco Maura, Ola Landgren, Fenghuang Zhan, Frits van Rhee, Carolina Schinke, Faith E. Davies, Gareth J. Morgan, Brian A. Walker |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-20524-2 |
Similar Items
-
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
by: Leo Rasche, et al.
Published: (2022-08-01) -
Variability of definition of high‐risk multiple myeloma across phase III clinical trials
by: Faris Jamal Abu Za'nouneh, et al.
Published: (2023-05-01) -
A gene signature can predict risk of MGUS progressing to multiple myeloma
by: Fumou Sun, et al.
Published: (2023-06-01) -
CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
by: Dongzheng Gai, et al.
Published: (2022-09-01) -
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
by: L. Rasche, et al.
Published: (2017-08-01)